PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell - FineTest ELISA Kit | FineTest Antibody | Wuhan Fine Biotech Co., Ltd.
Anti-PD-1 Blocking Antibody Inhibits Murine Melanoma Growth in... | Download Scientific Diagram
Frontiers | PD-1/PD-L1 Based Combinational Cancer Therapy: Icing on the Cake | Pharmacology
A human programmed death-ligand 1-expressing mouse tumor model for evaluating the therapeutic efficacy of anti-human PD-L1 antibodies | Scientific Reports
FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD- L1 Axis: Cancer Cell
Anti-PD-L1 mIgG1e3 monoclonal antibody | Atezolizumab-based
Frontiers | Resistance Mechanisms of Anti-PD1/PDL1 Therapy in Solid Tumors | Cell and Developmental Biology
Human PD-1 Antibody (PD1.D3), mAb, Mouse - GenScript
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells | Clinical Cancer Research
A. C57BL/6 mice were intraperitoneally treated with an anti-PD-1... | Download Scientific Diagram
Lenvatinib plus anti-PD-1 antibody combination treatment activates CD8+ T cells through reduction of tumor-associated macrophage and activation of the interferon pathway
PD-L1 Neutralizing Antibody
Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy | Journal for ImmunoTherapy of Cancer | Full Text
Mouse PD-1 Antibody AF1021: R&D Systems
Bio X Cell - InVivoMAb anti-mouse PD-1 (CD279)
Bio X Cell - PD1 Antibodies
Anti-mouse PD-1 (CD279) Antibody | Recombinant RMP1-14 | InvivoGen
Release the B7.1! Anti-PD-L1 breaks PD-L1's grip
Characterization of the Anti–PD-1 Antibody REGN2810 and Its Antitumor Activity in Human PD-1 Knock-In Mice | Molecular Cancer Therapeutics
Engineering high-affinity PD-1 variants for optimized immunotherapy and immuno-PET imaging | PNAS
TLR4 signaling improves PD-1 blockade therapy during chronic viral infection
The FG Loop of PD-1 Serves as a “Hotspot” for Therapeutic Monoclonal Antibodies in Tumor Immune Checkpoint Therapy - ScienceDirect
Anti-PD-1 antibody decreases tumour-infiltrating regulatory T cells | BMC Cancer | Full Text
